Message from President and CEO

Momentum, hope, progress: These are the words used to express the energy around brain cancer research these days.

   
  Spotlight on Research – 
2007 Project Awards

Accelerate Brain Cancer Cure announces a record number of grants – investing $1.5M, a 100% increase, to support breakthrough research at leading institutions throughout the country.

 
   
 
 

Diagnostic and Prognostic Biomarkers of Disease Status and Response to Therapy in Glioma

KEN ALDAPE , M.D.

M.D. Anderson Cancer Center, “Multigene Predictors of Outcome in Glioblastoma.”

  PANOS ANASTASIADIS, Ph.D.

The Mayo Clinic, “Cadherins and Catenins as Biomarkers of Pediatric and Adult Glioma Aggressiveness.”

  MARKUS BREDEL, M.D., Ph.D.

Northwestern University, “Predicting the Therapy Response of High-Grade Gliomas Based on a Network of Endogenous Modulators of Nuclear Factor-kappaB.”

  MENG LAW , M.D.

Mount Sinai Medical Center, “Standardization of Perfusion MR Imaging and Predicting Clinical Outcome in Patients with Gliomas Using Perfusion MR Metrics in a Multi-Institutional Setting.”

 
 

Development of Molecularly Targeted Therapeutics for Brain Cancer

ALAN D'ANDREA, M.D.

Dana Farber, “Inhibition of ATM and CHK2 as Treatment for Glioblastoma Multiforme.”

  XING FAN, M.D., Ph.D.

Johns Hopkins University, “Depleting Cancer Stem Cells by Notch Pathway Blockade in Glioblastomas."

  QIHONG HUANG, M.D., Ph.D.

The Wistar Institute, “Development of MicroRNA Inhibitors for the Treatment of Glioblastomas.”

  GARY LANDRETH, Ph.D.

Case Western Reserve University, “Efficacy of PPARg Agonists in Treatment of Glioma."

  DUANE MITCHELL, M.D., Ph.D.

Duke University Medical Center, “RNA Loaded Dendritic Cell Vaccines Targeting Brain Tumor Stem Cells During Hematopoietic Recovery from Temozolomide-induced Lymphopenia.”

  INDER VERMA, Ph.D.

The Salk Institute for Biological Studies, “Novel Therapies for Glioblastoma."

  ALFRED YUNG, M.D.

M.D. Anderson Cancer Center, “Identification of Compensatory Molecular Pathways Using Functional Genomic and Synthetic Lethality Screening in Glioblastoma Treated with PI3K Inhibitors.”

 

Co-funded with the Tug McGraw Foundation

  JOSEPH COSTELLO, Ph.D.

University of California San Francisco, “Evolution of a Hypomethylated and Hyperproliferative Phenotype in Glioblastoma Multiforme (GBM) and its Reversal by a High Methyl-donor Regimen.”

 
   
  The 10th Annual Cassidy & Pinkard Colliers Race for Hope

On May 6th, 6,000 individuals gathered in Washington, DC to a record high of $1.4 million in support of the brain tumor community

 
   
  Celebration of Hope

Stacey Case was joined by 200 of San Francisco's preeminent business leaders, friends and family for an evening filled with dinner, dancing, laughter and memories.

 
   

 

Message from President and CEO
Spotlight on Research –
2007 Project Awards
Ken Aldape, M.D.
  Panos Anastasiadis, PhD
  Markus Bredel, M.D., PhD
  Meng Law, M.D.
  Alan D'Andrea, M.D.
  Xing Fan, M.D., PhD
  Qihong Huang, M.D., PhD
  Gary Landreth, PhD
  Duane Mitchell, M.D., PhD
  Inder Verma, PhD
  Alfred Yung, M.D.
  Joseph Costello, PhD
The 10th Annual Cassidy & Pinkard Colliers Race for Hope
Celebration of Hope

 

Help Us to ACCELERATE a Brain Cancer Cure!

Are you looking for an opportunity to get involved in the fight against brain cancer? We have a new online tool called Firstgiving that allows you to create, personalize and market your own fundraising page.

The funds you raise directly support the research efforts of Accelerate Brain Cancer Cure. Learn more and sign up today at www.firstgiving.com/abc2 or contact our Director of Development Shannon Sullivan at 202.419.3140 or shannon.sullivan@abc2.org.

   

 

 

 

 

For questions, comments, or if you know of someone who would like to receive an electronic copy of Advance, please send and email to admin@abc2.org or call our office at 202.419.3140.

If you would like to be removed from our distribution list, please send an email to: admin@abc2.org.

1717 Rhode Island Ave NW | Suite 700 | Washington, DC 20036
Phone: 202/419-3140 | Fax: 202/419-3141 | Email: admin@abc2.org | www.abc2.org